Autolus Therapeutics plc - ADR Live Share Price Today, Share Analysis and Chart

Name: Autolus Therapeutics plc - ADR: Is Infosys Ltd. worth buying?
Item: Autolus Therapeutics plc - ADR
Rating: 1.49850
Author: Trendlyne DVM scores

about

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUT...

2.47 0.11 (4.66%)

50.60% Fall from 52W High

1.5M

XNAS Volume

XNAS 09 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

12.0 / 100

Technically Neutral

47.9 / 100

1Yr Price target upside is 299%

9 analysts

Autolus Therapeutics plc -... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Autolus Therapeutics plc - ADR Live Share Price Today, Share Analysis and Chart

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUT...

50.60% Fall from 52W High

SWOT Analysis

Autolus Therapeutics plc -... Live Price Chart